Skip to main content
Clinical Trials/NCT06959498
NCT06959498Not yet recruitingNot Applicable

Long-term Survival of THA After Pelvic and/or Femoral Osteotomy

Central Hospital, Nancy, France0 sites20 target enrollmentStarted: May 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Primary Endpoint
survival

Study Overview

Brief Summary

Analyze the long-term clinical and radiological outcomes of total hip arthroplasty (THA) in patients with hip dysplasia treated by pelvic osteotomy, femoral osteotomy, shelf acetabuloplasty, or a combination of these interventions, performed during childhood or early adulthood. The aim is to understand the impact of these early interventions on THA survival and long-term joint function.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients who underwent THA between 1998 and 2010 and had a prior surgical treatment for hip dysplasia (pelvic, femoral osteotomy, shelf acetabuloplasty or combined osteotomy)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

survival

Time Frame: 20 years

Study of 15 year survival of THA

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Central Hospital, Nancy, France
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olivier ROCHE

Dr

Central Hospital, Nancy, France

Similar Trials